Hong Kong
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.24 M
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
|
2 |
USD -13.65 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
3 |
USD -87.63 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
4 |
USD -291.14 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
The Vaccines company in Hong Kong with the highest Net Cash Used For Investing Activities is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD 5.24 M.
The Vaccines company in Hong Kong with the lowest Net Cash Used For Investing Activities is HUTCHMED (China) Limited (HKSE: 0013.HK) at USD -291.14 M.
The top 10 Vaccines companies in Hong Kong by Net Cash Used For Investing Activities are Regencell Bioscience Holdings Limited, SinoMab BioScience Limited, Frontage Holdings Corporation and HUTCHMED (China) Limited.
The bottom 10 Vaccines companies in Hong Kong by Net Cash Used For Investing Activities are HUTCHMED (China) Limited, Frontage Holdings Corporation, SinoMab BioScience Limited and Regencell Bioscience Holdings Limited.